National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 77473-77474 [2013-30404]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 246 / Monday, December 23, 2013 / Notices
Registration: Pre-registration is
recommended to expedite check-in.
Seating in the meeting room is limited
to room capacity and on a first come,
first served basis. To register, please
visit: www.iacc.hhs.gov.
Deadlines: Notification of intent to
present oral comments: Tuesday,
January 7, 2014 by 5:00 p.m. ET.
Submission of written/electronic
statement for oral comments:
Wednesday, January 8, 2014 by 5:00
p.m. ET. Submission of written
comments: Wednesday, January 8, 2014
by 5:00 p.m. ET. Please note: The NIMH
Office of Autism Research Coordination
(OARC) anticipates that written public
comments received by 5:00 p.m. ET,
Wednesday, January 8, 2014 will be
presented to the Committee prior to the
January 14th meeting for the
Committee’s consideration. Any written
comments received after the 5:00 p.m.
EST, January 8, 2014 deadline through
January 13, 2014 will be provided to the
Committee either before or after the
meeting, depending on the volume of
comments received and the time
required to process them in accordance
with privacy regulations and other
applicable Federal policies.
Access: Medical Center Metro (Red
Line).
Contact Person: Ms. Lina Perez, Office
of Autism Research Coordination,
National Institute of Mental Health,
NIH, 6001 Executive Boulevard, Room
6182A, Bethesda, MD 20892–9669,
Phone: 301–443–6040, Email:
IACCPublicInquiries@mail.nih.gov.
Public Comments: Any member of the
public interested in presenting oral
comments to the Committee must notify
the Contact Person listed on this notice
by 5:00 p.m. ET on Tuesday, January 7,
2014, with their request to present oral
comments at the meeting. Interested
individuals and representatives of
organizations must submit a written/
electronic copy of the oral presentation/
statement including a brief description
of the organization represented by 5:00
p.m. ET on Wednesday, January 8, 2014.
Statements submitted will become a
part of the public record. Only one
representative of an organization will be
allowed to present oral comments and
presentations will be limited to three to
five minutes per speaker, depending on
number of speakers to be accommodated
within the allotted time. Speakers will
be assigned a time to speak in the order
of the date and time when their request
to speak is received, along with the
required submission of the written/
electronic statement by the specified
deadline.
In addition, any interested person
may submit written comments to the
VerDate Mar<15>2010
18:12 Dec 20, 2013
Jkt 232001
IACC prior to the meeting by sending
the comments to the Contact Person
listed on this notice by 5:00 p.m. ET on
Wednesday 8, 2014. The comments
should include the name, address,
telephone number and when applicable,
the business or professional affiliation
of the interested person. NIMH
anticipates written public comments
received by 5:00 p.m. ET, Wednesday,
January 8, 2014 will be presented to the
Committee prior to the meeting for the
Committee’s consideration. Any written
comments received after the 5:00 p.m.
EST, January 8, 2014 deadline through
January 13, 2014 will be provided to the
Committee either before or after the
meeting, depending on the volume of
comments received and the time
required to process them in accordance
with privacy regulations and other
applicable Federal policies. All written
public comments and oral public
comment statements received by the
deadlines for both oral and written
public comments will be provided to
the IACC for their consideration and
will become part of the public record.
In the 2009 IACC Strategic Plan, the
IACC listed the ‘‘Spirit of Collaboration’’
as one of its core values, stating that,
‘‘We will treat others with respect, listen
to diverse views with open minds,
discuss submitted public comments,
and foster discussions where
participants can comfortably offer
opposing opinions.’’ In keeping with
this core value, the IACC and the NIMH
Office of Autism Research Coordination
(OARC) ask that members of the public
who provide public comments or
participate in meetings of the IACC also
seek to treat others with respect and
consideration in their communications
and actions, even when discussing
issues of genuine concern or
disagreement.
Remote Access: The meeting will be
open to the public through a conference
call phone number and webcast live on
the Internet. Members of the public who
participate using the conference call
phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with
the webcast or conference call, please
send an email to
helpdeskiacc@gmail.com or by phone at
415–652–8023.
Individuals who participate in person
or by using these electronic services and
who need special assistance, such as
captioning of the conference call or
other reasonable accommodations,
should submit a request to the Contact
Person listed on this notice at least 5
days prior to the meeting.
Security: In the interest of security,
NIH has instituted stringent procedures
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
77473
for entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit. Also as a part of
security procedures, attendees should
be prepared to present a photo ID at the
meeting registration desk during the
check-in process. Pre-registration is
recommended. Seating will be limited
to the room capacity and seats will be
on a first come, first served basis, with
expedited check-in for those who are
pre-registered.
Meeting schedule subject to change.
Information about the IACC is
available on the Web site: https://
www.iacc.hhs.gov.
Dated: December 17, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–30397 Filed 12–20–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Centers for AIDS Research
and Developmental Centers for AIDS
Research (P30).
Date: January 13–14, 2014.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Jay Bruce Sundstrom,
Ph.D., Scientific Review Officer, Scientific
Review Program, DEA/NIAID/NIH/DHHS,
E:\FR\FM\23DEN1.SGM
23DEN1
77474
Federal Register / Vol. 78, No. 246 / Monday, December 23, 2013 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Plasticity and Neural Stem Cells.
Date: January 7, 2014.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Laurent Taupenot, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4811,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, taupenol@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Hematopoiesis, Hemoglobin and
Hypertension.
Date: January 23, 2014–January 24, 2015.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Natalia Komissarova,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
MSC 7846, Bethesda, MD 20892, 301–435–
1206, komissar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846-93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 17, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: December 17, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–30404 Filed 12–20–13; 8:45 am]
[FR Doc. 2013–30408 Filed 12–20–13; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
6700B Rockledge Drive, MSC–7616,
Bethesda, MD 20892, 301–496–7042,
sundstromj@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Pharmacological
Approaches to Evaluating Drug Regimens to
Address Antimicrobial Resistance (R01).
Date: January 14–15, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Susquehanna/Severn
Suite, 7400 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Frank S. De Silva, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–594–1009, fdesilva@
niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: January 14, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 6700–B
Rockledge Dr., MSC–7616, Bethesda, MD
20892–7616, 301–496–2550, robert.unfer@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
Institute of Mental Health.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
VerDate Mar<15>2010
18:12 Dec 20, 2013
Jkt 232001
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
NATIONAL INSTITUTE OF MENTAL
HEALTH, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, National Institute of Mental
Health.
Date: January 21–22, 2014.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hilton Washington/Rockville
Regency Room, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: A. Roger Little, Ph.D.,
Executive Secretary, Board of Scientific
Counselors, National Institute of Mental
Health, National Institutes of Health, 6001
Executive Blvd., Room 6132, Bethesda, MD
20892–9609, 301–402–5844, alittle@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS).
Dated: December 17, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–30398 Filed 12–20–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, Center for
Engineered Cartilage (2014/05).
Date: February 14, 2014.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\23DEN1.SGM
23DEN1
]]>Agencies
[Federal Register Volume 78, Number 246 (Monday, December 23, 2013)]
[Notices]
[Pages 77473-77474]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-30404]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Centers for AIDS Research and
Developmental Centers for AIDS Research (P30).
Date: January 13-14, 2014.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Jay Bruce Sundstrom, Ph.D., Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS,
[[Page 77474]]
6700B Rockledge Drive, MSC-7616, Bethesda, MD 20892, 301-496-7042,
sundstromj@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Pharmacological Approaches to
Evaluating Drug Regimens to Address Antimicrobial Resistance (R01).
Date: January 14-15, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center,
Susquehanna/Severn Suite, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Frank S. De Silva, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 6700B Rockledge
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-594-1009,
fdesilva@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
Date: January 14, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Robert C. Unfer, Ph.D., Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700-B
Rockledge Dr., MSC-7616, Bethesda, MD 20892-7616, 301-496-2550,
robert.unfer@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS).
Dated: December 17, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-30404 Filed 12-20-13; 8:45 am]
BILLING CODE 4140-01-P
